Alphabetical Search: 1 2 3 4 5 6 7 8 9 A B C D E F G H I K M N O P T U X
  Searchbox: Selection of cyclic nucleotides by properties.
Subcategories for Cyclic Nucleotides
PDE- resistant PKA Inhibitors
PDE- resistant PKA Activators
Epac Agonists
Epac- negative Controls
Other PKA Activators
PDE- resistant PKG Inhibitors
PDE- resistant PKG Activators
Other Activators of PKG
Affinity Gels
cAMP Ligands for Immobilization
cGMP Ligands for Immobilization
Caged Cyclic Nucleotides
Special Task Cyclic Nucleotides
Modulators of CNG Ion Channels
Fluorescent Cyclic Nucleotides
Peptide-based PKG Inhibitors
Metabolically activatable cNMP
cNMP with Pyrimidine Nucleobase
Classification
Bulk
cAMP modified at the exocyclic oxygen - equatorial (Rp-)
cAMP modified at the exocyclic oxygen - axial (Sp-)
cGMP modified at the exocyclic oxygen - equatorial (Rp-)
cGMP modified at the exocyclic oxygen - axial (Sp-)
Position of Purine Nucleobase Modification:
Description:
Lipophilicity

Lipophilicity ranking is based on log kw data. To be membrane-permeant, analogues should have a log kw of at least 1.2

<< Back
Forgot your password?
Register
Username:
Password:
What is new!

February 10, 2012

PKG Inhibitor Peptide W45

W45 which can be used as a control peptide in applications of the peptide-based protein kinase G... [more...]

January 13, 2012

6-Fu-ATP-γ-S reference

Lo & Hollingsworth have successfully used 6-Fu-ATP-γ-S (Cat. No. F 008) from BIOLOG in... [more...]